AzTrials
AzTrials

PainHYPNOICUNCT04399850

Impact of Hypnosis During Invasive Procedure in Intensive Care Unit

A study testing Hypnosis group in people with Pain, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pain during ICU stay remains one of the major complaints for patients. Beside pain intensity, well described by patients' self reports, pain distress, which is an emotional experience, cannot be treated with usual analgesia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pain
What is being tested?
Hypnosis group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
124 participants
Where
1 siteFrance
Study dates
28 Sep 2020to 28 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients aged 18 years and older
  • ICU hospitalisation
  • Non-sedated patients who need an invasive procedure (Invasive procedures are defined as chest tube (insert or remove), fibroscopy, catheter insert, lumbar punction and bone marrow aspiration)
  • Physician experienced in hypnosis available
  • written informed consent
  • health insurance

Who cannot join

  • sedation and intubation, delirium, end-of-life decision,
  • deaf patient,
  • patient who does not understand French language,
  • pregnancy
  • patient under guardianship or curatorship
  • lack of health insurance

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Saint-Louis

    Paris

Other trials in France

About this study

Pain during ICU stay remains one of the major complaints for patients. Beside pain intensity, well described by patients' self reports, pain distress, which is an emotional experience, cannot be treated with usual analgesia. The aim of the study is to analyze the impact of hypnosis on pain intensity and distress on short and long term outcomes in non-sedated ICU patients.

Conditions
Pain
Being tested
Hypnosis group
Keywords
invasive procedure, pain distress, hypnosis
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypnosis groupOther

    Patients who receive hypnosis

Study groups in NCT04399850
Study groupRoleWhat they receive
Patients who receive hypnosisExperimentalPatients who receive hypnosis during procedure by experiment physician
Receives: Other: Hypnosis group
Control armNo interventionPatient with conventional pain management

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain distress

    Pain distress change in the hypnosis group measured before and within the first hour after the procedure.

    Pain distress will be assessed using Numeric rating scale, which goes from 0 (no pain stress) to 10 (maximum pain stress).

    Measured: within the before and the first hour after the procedure

Secondary outcomes (10)
  1. Pain intensity

    Pain intensity will be assessed using Numeric rating scale, which goes from 0 (no pain) to 10 (maximum pain imaginable).

    Measured: within first hour and first 24 hours after procedure

  2. Number of adverse events

    Measured: during procedure

  3. Length of each painful procedure

    Measured: up to 3 months

  4. Analgesia dose

    The dose of each analgesia treatment received by the patient will be collected.

    Measured: within first and 24 hours after procedure

  5. Type of analgesia

    The type of each analgesia treatment received by the patient will be collected.

    Measured: within first and 24 hours after procedure

  6. Anxiety

    Anxiety within first and 24 hours after procedure will be assessed using Numeric rating scale, which goes from 0 (no anxiety) to 10 (maximum anxiety imaginable).

    Measured: within first and 24 hours after procedure

  7. Hospital Anxiety and Depression (HAD) scale

    The HAD scale is a self-assessment scale for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic.

    HAD scale is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). A higher score indicates worse outcome.

    Measured: at 3 months

  8. Post traumatic stress disorder assessed using Impact of Event Scale Revisited (IES R)

    The IES-R is a 22-item self-report measure (for DSM-IV) that assesses subjective distress caused by traumatic events. Items are rated on a 5-point scale ranging from 0 to 4 . The IES-R yields a total score (ranging from 0 to 88)

    Measured: at 3 months

  9. Proportion of patients who had hypnosis transe

    Measured: during procedure

  10. Description of the experience of hypnosis

    Qualitative analysis of the experience of hypnosis will be performed using the semi-structured interview

    Measured: at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2020
  2. Study start28 Sep 2020
  3. Primary completion28 Mar 2024
  4. Study completion28 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
124 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04399850
Sponsor's protocol ID
APHP191042
Acronym
HYPNOICU
Status last verified
Jul 2024
First submitted
29 Apr 2020
Last updated
17 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis group in people with Pain, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain distress (time frame: within the before and the first hour after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in